Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
SI-WARE SYSTEMS	100 FOOTHILL BLVD # M LA CANADA FLINTRIDGE CA 91011

International Classification(s)

• H03L:AUTOMATIC CONTROL, STARTING, SYNCHRONISATION, OR S....
• H03B:GENERATION OF OSCILLATIONS, DIRECTLY OR BY FREQUEN....

• 2016 Application Filing Year
• H03L Class
• 676 Applications Filed
• 589 Patents Issued To-Date
• 87.14 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Bahry, Mohamed Abd El-Moneim	Cairo, EG	1	0
# of filed Patents : 1 Total Citations : 0
El-Aassar, Omar Essam	Helipolis, EG	6	5
# of filed Patents : 6 Total Citations : 5
Eldin, Mohamed AS	Cairo, EG	2	2
# of filed Patents : 2 Total Citations : 2
Elkhouly, Ahmed	Champaign, US	1	0
# of filed Patents : 1 Total Citations : 0
ElSayed, Ahmed	Heliopolis, EG	7	26
# of filed Patents : 7 Total Citations : 26
Helmy, Ahmed	Rehab City, EG	8	96
# of filed Patents : 8 Total Citations : 96
Mikhael, David HG	Cairo, EG	1	0
# of filed Patents : 1 Total Citations : 0
Sinoussi, Nabil	El-Shorook, EG	3	3
# of filed Patents : 3 Total Citations : 3

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• H03L Class

• 0 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Mar 29, 2028

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2015/0065,462

CONJUGATES OF A PHOSPHOLIPID AND A DRUG FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

---

Abstract

---

Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA₂.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.